Critical Environments Columns
-
Expert Voices: Why Aren't QC Labs Fully Automated Yet?
10/4/2024
Leading automation experts chime in on why QC labs, otherwise ideal for robotics, have been slow to adopt and standardize the technology.
-
The Influence Of Flows In cGMP Architectural Design
8/22/2024
In drug manufacturing facility layout, balancing the roles of layout and procedure plays a critical role. This article examines how the interplay may be resolved, and how this resolution affects facility layout during design.
-
Are You Taking The HPCs In Your ADCs Seriously?
8/16/2024
The wave of ADC (antibody-drug conjugate) development and manufacturing activity we’re currently witnessing, and importantly, the HPC (high-potency compounds) comprising the payloads in these therapies, demand thorough assessment of development and manufacturing facility design.
-
This Takeda Official Thinks Pharma 4.0 Won't Be Optional Much Longer
8/14/2024
Advanced technology like automation was once seen only as a competitive advantage. That viewpoint is shifting amid greater reliance on digital technology.
-
2024 Emerging Trends In Cleanroom Technologies
8/14/2024
This article shares new market research on pharma/biotech cleanroom technologies, including regional trends, prominent vendors in the space, and more.
-
BPSA's Single-Use Summit Celebrates Its "Stainless" Anniversary
7/29/2024
The Bio Process Systems Alliance (BPSA) is devoted to the advance of single-use technologies in biopharmaceutical manufacturing. At its 11th International Single-Use Summit, the explosive growth in single-use was on full display, and the sourcing, safety, sustainability, and application discussions on the agenda were comprehensive.
-
How Eli Lilly's Making Peptides Faster And More Reliably
7/17/2024
Three company leaders answer questions about the IE2b project, which is receiving an ISPE 2024 Facility of the Year Award for its ingenuity of complexity.
-
Chugai's Race To Zero Emissions At UK4 In Tokyo
6/21/2024
Chugai's sustainable model led the construction of a new DS/DP manufacturing site, UK4, in Tokyo. The company focused on eliminating three key emissions sources.
-
Design And Function Of GMP Transition Spaces
6/12/2024
In pharma/biotech GMP, there are several spaces that function as transition spaces, such as air locks. This deep dive discusses how procedure and arrangement can influence their effectiveness.
-
Are Annex 1's CCS Requirements Still Challenging You?
6/5/2024
Contamination control strategies are nothing new, but their inclusion in the Annex 1 update represents one of the revision's few new requirements.